Novartis International AG / Novartis PKC412 (midostaurin) pivotal data published in NEJM show 60% response rate in advanced systemic mastocytosis (SM) . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible...
Source : http://www.romandie.com/news/Novartis-Internationa...
Source : http://www.romandie.com/news/Novartis-Internationa...